TANG CAPITAL MANAGEMENT LLC Diversified Active

CIK: 0001232621 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value ($000): $739,969 (100.0% shares, 0.0% debt)

Holdings (10)

— ODONATE THERAPEUTICS INC 69.8%

Value ($000) $516,422 Shares 14,075,269 Est. Cost $25.08 Unrealized —

HRTX HERON THERAPEUTICS INC 14.4%

Value ($000) $106,783 Shares 5,744,096 Est. Cost $14.10 Unrealized +41.7%

— LA JOLLA PHARMACEUTICAL CO 6.2%

Value ($000) $45,685 Shares 4,938,893 Est. Cost $15.94 Unrealized —

RCKT ROCKET PHARMACEUTICALS INC 6.0%

Value ($000) $44,482 Shares 2,965,485 Est. Cost $16.31 Unrealized +7.0%

— CELGENE CORP 1.4%

Value ($000) $10,339 Shares 111,844 Est. Cost $94.34 Unrealized —

— G1 THERAPEUTICS INC 0.8%

Value ($000) $6,132 Shares 200,000 Est. Cost $30.66 Unrealized —

PBYI PUMA BIOTECHNOLOGY INC 0.6%

Value ($000) $4,441 Shares 349,400 Est. Cost $30.17 Unrealized -23.7%

PRTA PROTHENA CORP PLC 0.5%

Value ($000) $3,423 Shares 323,823 Est. Cost $12.40 Unrealized -17.2%

— CELLECTAR BIOSCIENCES INC 0.2%

Value ($000) $1,482 Shares 680,000 Est. Cost $2.18 Unrealized —

— IVERIC BIO INC 0.1%

Value ($000) $780 Shares 600,000 Est. Cost $1.30 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ODONATE THERAPEUTICS INC	14,075,269	$516,422	69.8%	$25.08	—	COM	676079106
HRTX	HERON THERAPEUTICS INC	5,744,096	$106,783	14.4%	$14.10	+41.7%	COM	427746102
—	LA JOLLA PHARMACEUTICAL CO	4,938,893	$45,685	6.2%	$15.94	—	COM	503459604
RCKT	ROCKET PHARMACEUTICALS INC	2,965,485	$44,482	6.0%	$16.31	+7.0%	COM	77313F106
—	CELGENE CORP	111,844	$10,339	1.4%	$94.34	—	COM	151020104
—	G1 THERAPEUTICS INC	200,000	$6,132	0.8%	$30.66	—	COM	3621LQ109
PBYI	PUMA BIOTECHNOLOGY INC	349,400	$4,441	0.6%	$30.17	-23.7%	COM	74587V107
PRTA	PROTHENA CORP PLC	323,823	$3,423	0.5%	$12.40	-17.2%	SHS	G72800108
—	CELLECTAR BIOSCIENCES INC	680,000	$1,482	0.2%	$2.18	—	COM PAR	15117F500
—	IVERIC BIO INC	600,000	$780	0.1%	$1.30	—	COM	46583P102